Results 141 to 150 of about 8,456 (172)
Some of the next articles are maybe not open access.
Observations on Prostaglandin Orbitopathy
Ophthalmic Plastic & Reconstructive Surgery, 2016To present the various orbital soft-tissue changes that can result from the use of topical prostaglandin analogs.A case series of patients seen in a referral oculoplastic practice with presumed prostaglandin orbitopathy.Thirty-five patients were found to have a variety of disorders, including deepening of the superior sulci (24/35), hypertrichosis (32 ...
Philip L, Custer, Tiffany L, Kent
openaire +2 more sources
Current concepts regarding Graves’ orbitopathy
Journal of Internal Medicine, 2022Luigi Bartalena, Maria Laura Tanda
exaly
Klinische Monatsblatter fur Augenheilkunde, 2011
Graves' orbitopathy (GO) is part of an autoimmune systemic disease (prevalence of 0.5 - 2%) which is composed of hyperthyroidism, orbitopathy, dermopathy and acropachy. Stimulating antibodies against the TSH receptor plays the central pathogenetic role and high levels indicate the risk of a severe course of the disease. The main symproms of GO comprise
A, Eckstein, J, Esser
openaire +1 more source
Graves' orbitopathy (GO) is part of an autoimmune systemic disease (prevalence of 0.5 - 2%) which is composed of hyperthyroidism, orbitopathy, dermopathy and acropachy. Stimulating antibodies against the TSH receptor plays the central pathogenetic role and high levels indicate the risk of a severe course of the disease. The main symproms of GO comprise
A, Eckstein, J, Esser
openaire +1 more source
Polydatin attenuates orbital oxidative stress in Graves’ orbitopathy through the NRF2 pathway
Chemico-Biological Interactions, 2020ｈｏｎｇ Ｌｉ, Jie Min
exaly
Adipocytokines in Graves’ orbitopathy and the effect of high-dose corticosteroids
Adipocyte, 2021Jan Schovanek +2 more
exaly